SuperworthFuller H B free cash flow FUL
Cash from operations less capital spending, by quarter and over the last twelve months, from 2009.
- Last 12 months, to Aug 29, 2026
- $100M
- Latest quarter, Q3 FY26
- $28.2M
- −59% on a year earlier
- Fiscal year 2025
- $121.2M
- −26% on the year before
Fuller H B's free cash flow was $100M over the twelve months to Aug 29, 2026, down 18% on a year earlier.
In its latest quarter, Q3 FY26, it was $28.2M, down 59% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 13% a year on average.
Free cash flow over time
Fiscal year by fiscal year
| Fiscal year | Free cash flow | Change |
|---|---|---|
| FY2025 | $121.2M | −26% |
| FY2024 | $163.2M | −37% |
| FY2023 | $259.3M | +105% |
| FY2022 | $126.5M | +8% |
| FY2021 | $117.2M | −52% |
| FY2020 | $244.3M | +18% |
| FY2019 | $207.2M | +12% |
| FY2018 | $185M | +116% |
| FY2017 | $85.9M | −35% |
| FY2016 | $132.4M | −13% |
| FY2015 | $151.9M | +718% |
| FY2014 | $18.6M | +23% |
| FY2013 | $15.1M | −79% |
| FY2012 | $72.7M | +9% |
| FY2011 | $66.5M | +74% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | Free cash flow | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $28.2M | −59% | $100M | |
| Q2 FY26 | $74.5M | −6% | $140.8M | |
| Q1 FY26 | −$61.7M | n/a | $145.4M | |
| Q4 FY25 | $59.1M | −0% | $121.2M | |
| Q3 FY25 | $68.9M | +6% | $121.4M | |
| Q2 FY25 | $79.1M | +128% | $117.6M | |
| Q1 FY25 | −$85.9M | −2217% | $73.3M | |
| Q4 FY24 | $59.2M | −61% | $163.2M | |
| Q3 FY24 | $65.2M | −20% | $256.1M | |
| Q2 FY24 | $34.7M | −49% | $272.2M | |
| Q1 FY24 | $4.1M | n/a | $305.4M | |
| Q4 FY23 | $152.1M | −14% | $259.3M |
Against its peers
Companies in Chemicals nearest Fuller H B's size, closest first, today.
| Company | Free cash flow yield |
|---|---|
| FULFuller H B | 3.7% |
| WDFCWD 40 | 2.8% |
| IOSPInnospec | 2.9% |
| NGVTIngevity | 6.5% |
| ROGRogers | 3.7% |
| AVNTAvient | 5.1% |
| CBTCabot | 7.4% |
| CSWCSW Industrials | 3.0% |
| BCPCBalchem | n/m |
| CRONCronos | 4.0% |
| HXLHexcel | 4.2% |
| Peer median | 4.0% |
Where Fuller H B ranks
What the free cash flow tells you
Cash from operations minus capital spending. The cash the company could hand back or reinvest.
Seasonal and lumpy quarter to quarter. The TTM view is the one to trust.
More on Fuller H B
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.